Yantai Dongcheng Biochemicals Co. Ltd. | Ownership
Companies that own Yantai Dongcheng Biochemicals Co. Ltd.
Baoying Fund Management Co., Ltd.
8,343,149
1.44%
-11,687,284
0.43%
12/31/2017
Zhongrong Fund Management Co. Ltd.
3,560,100
0.62%
-4,439,900
0.72%
03/31/2018
Bosera Asset Management Co., Ltd.
3,500,000
0.61%
3,500,000
0.04%
03/31/2018
Zhonghai Fund Management Co., Ltd.
3,000,708
0.52%
2,905,423
0.49%
12/31/2017
Zhong Ou Asset Management Co., Ltd
2,775,090
0.48%
2,775,090
0.07%
12/31/2017
Huatai-PineBridge Fund Management Co., Ltd.
1,676,800
0.28%
1,632,300
0.05%
12/31/2017
Rongtong Fund Management Co., Ltd.
1,552,847
0.27%
-4,565,665
0.08%
12/31/2017
Guotai Junan Allianz Fund Management Co., Ltd.
1,264,701
0.22%
94,000
0.1%
12/31/2017
Beixin Ruifeng Fund Management Co. Ltd.
610,400
0.11%
-339,600
0.02%
12/31/2017
The Vanguard Group, Inc.
426,300
0.07%
0
0%
07/31/2018
| Address |
No. 7 Changbaishan Road
Yantai Shandong 264006
China
|
|
Employees
|
- |
| Website |
http://www.dcb-group.com |
| Updated |
07/08/2019 |
| Yantai Dongcheng Biochemicals Co., Ltd. engages in the research and development, production, and marketing of biochemical active pharmaceutical ingredient (API). It involves in API, chemical synthetic drugs, and modern chinese medicines. The firm's products include heparin series, chondroitin sulphate, marine collagen, hyaluronic acid, glucosamine series, heparinoid, and cytochrome C. |
